Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Non-cash Items (2021 - 2026)

Organogenesis Holdings has reported Non-cash Items over the past 5 years, most recently at $20.0 million for Q4 2025.

  • For Q4 2025, Non-cash Items rose 692.26% year-over-year to $20.0 million; the TTM value through Dec 2025 reached $20.0 million, up 692.26%, while the annual FY2025 figure was $20.0 million, 692.26% up from the prior year.
  • Non-cash Items for Q4 2025 was $20.0 million at Organogenesis Holdings, up from $6.3 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $38.5 million in Q4 2021 and troughed at $1.5 million in Q1 2023.
  • A 5-year average of $8.3 million and a median of $5.4 million in 2023 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: tumbled 94.17% in 2022 and later soared 692.26% in 2025.
  • Year by year, Non-cash Items stood at $38.5 million in 2021, then tumbled by 94.17% to $2.2 million in 2022, then soared by 357.33% to $10.3 million in 2023, then plummeted by 75.45% to $2.5 million in 2024, then soared by 692.26% to $20.0 million in 2025.
  • Business Quant data shows Non-cash Items for ORGO at $20.0 million in Q4 2025, $6.3 million in Q3 2025, and $6.4 million in Q2 2025.